Evidence map›Paper›PMID 37239080›Full record

ArticleBiomedicines2023

SARS-CoV-2 Infection in Venezuelan Pediatric Patients-A Single Center Prospective Observational Study.

Francis Isamarg Crespo, Soriuska José Mayora, Juan Bautista De Sanctis, Wendy Yaqueline Martínez, Mercedes Elizabeth Zabaleta-Lanz, Félix Isidro Toro, Leopoldo Humberto Deibis, Alexis Hipólito García

Open access · goldAbstract read
In one paragraph

Article in Biomedicines, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.0field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Francis Isamarg CrespoInstitute of Immunology, Faculty of Medicine, Central University of Venezuela, Caracas 1040, Venezuela.
Soriuska José MayoraInstitute of Immunology, Faculty of Medicine, Central University of Venezuela, Caracas 1040, Venezuela.
Juan Bautista De SanctisInstitute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palacky University, 779 00 Olomouc, Czech Republic.ORCID 0000-0002-5480-4608
Wendy Yaqueline MartínezInstitute of Immunology, Faculty of Medicine, Central University of Venezuela, Caracas 1040, Venezuela.
Mercedes Elizabeth Zabaleta-LanzInstitute of Immunology, Faculty of Medicine, Central University of Venezuela, Caracas 1040, Venezuela.
Félix Isidro ToroInstitute of Immunology, Faculty of Medicine, Central University of Venezuela, Caracas 1040, Venezuela.
Leopoldo Humberto DeibisInstitute of Immunology, Faculty of Medicine, Central University of Venezuela, Caracas 1040, Venezuela.
Alexis Hipólito GarcíaInstitute of Immunology, Faculty of Medicine, Central University of Venezuela, Caracas 1040, Venezuela.ORCID 0000-0002-2354-0160
Central University of Venezuela · VEInstitute of Molecular and Translational Medicine · CZ

Funding

Fondo Nacional de Ciencia Tecnología e Innovación 202000PGPMinistry of Science. Venezuela CP19-03
6 · The paper itself

Abstract

Several studies suggest that children infected with SARS-CoV-2 have fewer clinical manifestations than adults; when they develop symptoms, they rarely progress to severe disease. Different immunological theories have been proposed to explain this phenomenon. In September 2020, 16% of the active COVID-19 cases in Venezuela were children under 19 years. We conducted a cross-sectional study of pediatric patients' immune response and clinical conditions with SARS-CoV-2 infection. The patients were admitted to the COVID-19 area of the emergency department of Dr José Manuel de los Ríos Children's Hospital (2021-2022). The lymphocyte subpopulations were analyzed by flow cytometry, and IFNγ, IL-6, and IL-10 serum concentrations were quantified using commercial ELISA assays. The analysis was conducted on 72 patients aged one month to 18 years. The majority, 52.8%, had mild disease, and 30.6% of the patients were diagnosed with MIS-C. The main symptoms reported were fever, cough, and diarrhea. A correlation was found between IL-10 and IL-6 concentrations and age group, lymphocyte subpopulations and nutritional status and steroid use, and IL-6 concentrations and clinical severity. The results suggest a different immune response depending on age and nutritional status that should be considered for treating pediatric COVID-19 patients.

Indexed as

COVID-19IFNγIL-10IL-6lymphocyte subpopulationsmalnutritionMIS-Cpediatric COVID-19steroids

Identifiers

PMID37239080
PMCPMC10216668
OpenAlexW4376115379

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.